Journal
BLOOD
Volume 128, Issue 25, Pages 2875-2877Publisher
AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2016-10-746719
Keywords
-
Categories
Ask authors/readers for more resources
In this issue of Blood, Basiorka et al have challenged how we think about cell death in myelodysplastic syndromes (MDS), proposed an explanation for the shared morphologic changes that are seen despite genetic heterogeneity, and identified a new target for therapeutic intervention.(1)
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
